Presently, there are six different multidistrict litigation consolidations with roughly 40,000 individual transvaginal mesh cases pending across the United States. Last year, Endo Pharmaceutical, Inc. paid out a $54.5 million dollar settlement to compensate victims injured by a mesh implant.
Transvaginal mesh is used to repair common pelvic floor disorders, including pelvic organ prolapse or stress urinary incontinence. It is designed to shore up organs such as the bladder and uterus that have dropped due to age, obesity, or childbirth.
According to the U.S. Food and Drug Administration, reported complications from the transvaginal placement of the mesh include erosion of the mesh into the vaginal tissue, organ perforation, pain, infection, painful intercourse, and urinary and fecal incontinence. Often women require surgery to remove the mesh, and in some cases, this can require multiple procedures.
With the number of transvaginal mesh and bladder sling cases growing, it's more important than ever for you to get up to date on the latest concerns, court cases, and legal remedies so you can best serve your clients. Learn more by participating in this timely webinar.
In just one hour, you'll learn:
- Regulatory framework: The role of the FDA
- Analysis of applicable preemption rulings: Product liability litigation in a post-Reigel world
- Available claims for 510(k) medical devices
- Current examples of how Daubert is being applied in device litigation
- Analysis of post-market product surveillance and clinical studies
- The lay of the litigation landscape -- venue, discovery, and proving your case
- And more!
Don't miss this update for Tennessee and Alabama attorneys.
The Uphill Battle of Piercing the Corporate Veil in Alabama - on CD
is just $107.